logo
Share SHARE
FONT-SIZE Plus   Neg

Prism Informatics Completes Realization Phase At Aamby Valley

Software development and strategic business consulting company Prism Informatics Ltd. announced the completion of realization phase at Aamby Valley Ltd. The purpose of this phase is to implement business and process requirements based on the Business Blueprint.

The objectives are final implementation in the system, an overall test, and the release of the system for productive (live) operation. The system is configured in two work packages, namely Baseline (major scope), and Final (remaining scope). Multiple module tests and the integration tests are carried out during this phase, the company said.

Along with the configuration phase sign-off, Prism has also completed training and User Acceptance Test (UAT) for the multiple modules including Financial Accounting, Controlling, Materials Management, Sales and Distribution and Human Resource.

Aamby Valley City is being developed as an Integrated Hill City spread over an area of 10,600 acres (4,294 hectares). It is positioned as a premium, self-contained city addressing the various socio-physical infrastructure requirements lie school, hospital, captive utilities (power, water, telecommunications), shopping facilities, and recreational areas. Aamby Valley City is located at a distance of 120 km from Mumbai, 90 km from Pune and lies 25 km off the town of Lonavala on the Mumbai Pune Expressway.

At the BSE, Prism Informatics closed Wednesday's trading at Rs.31.95, down 1.84 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT